Cargando…

How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?

Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) with the involvement of immune cells and molecules, including cytokines, chemokines and proteases. A previous extensive review about the molecular biology of matrix metalloproteases (MMPs) and tissue inhibitors of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Opdenakker, Ghislain, Vermeire, Séverine, Abu El-Asrar, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509204/ https://www.ncbi.nlm.nih.gov/pubmed/36164340 http://dx.doi.org/10.3389/fimmu.2022.983964

Ejemplares similares

Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease
por: de Bruyn, Magali, et al.
Publicado: (2017)

MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus
por: Ugarte-Berzal, Estefania, et al.
Publicado: (2019)

Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2016)

Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase
por: Vandooren, Jennifer, et al.
Publicado: (2018)

Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
por: Jacobs, Inge, et al.
Publicado: (2021)

Comparisons of gut microbiota profiles in wild-type and gelatinase B/matrix metalloproteinase-9-deficient mice in acute DSS-induced colitis
por: de Bruyn, Magali, et al.
Publicado: (2018)

Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants
por: Rossano, Rocco, et al.
Publicado: (2014)

Inhibition of Neutrophil Collagenase/MMP-8 and Gelatinase B/MMP-9 and Protection against Endotoxin Shock
por: Qiu, Zheng, et al.
Publicado: (2014)

The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2019)

New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2021)

Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease
por: Verstockt, Bram, et al.
Publicado: (2018)

Endothelial Response to Glucocorticoids in Inflammatory Diseases
por: Zielińska, Karolina A., et al.
Publicado: (2016)

Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2010)

Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2021)

Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium
por: Creyns, Brecht, et al.
Publicado: (2020)

Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms
por: Nuti, Elisa, et al.
Publicado: (2020)

Duality and Complexity of Allergic Type Inflammatory Mechanisms in Determining the Outcome of Malaria Disease
por: Blank, Ulrich, et al.
Publicado: (2011)

Vaccination and infection prevention in inflammatory bowel disease
por: Vermeire, Severine, et al.
Publicado: (2010)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer
por: Jauregui-Amezaga, Aranzazu, et al.
Publicado: (2016)

The ERK(1/2) Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina
por: Mohammad, Ghulam, et al.
Publicado: (2013)

Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
por: Alsoud, Dahham, et al.
Publicado: (2022)

New biologics and small molecules in inflammatory bowel disease: an update
por: Sabino, João, et al.
Publicado: (2019)

Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M, et al.
Publicado: (2014)

Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview
por: Pouillon, Lieven, et al.
Publicado: (2019)

A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease
por: Vyas, Shachi Pranjal, et al.
Publicado: (2018)

Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1
por: Vandooren, Jennifer, et al.
Publicado: (2017)

EDTA/gelatin zymography method to identify C1s versus activated MMP‐9 in plasma and immune complexes of patients with systemic lupus erythematosus
por: Ugarte‐Berzal, Estefania, et al.
Publicado: (2018)

Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases
por: Jakubowska, Katarzyna, et al.
Publicado: (2016)

Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study
por: Vandooren, Jennifer, et al.
Publicado: (2017)

Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease
por: Yokoyama, Masaya, et al.
Publicado: (2021)

Infliximab: the evidence for its place in therapy in ulcerative colitis
por: Van Assche, Gert, et al.
Publicado: (2007)

Duality of B Cell-CXCL13 Axis in Tumor Immunology
por: Rubio, Angel J., et al.
Publicado: (2020)

Interleukin-27 Functional Duality Balances Leishmania Infectivity and Pathogenesis
por: Jafarzadeh, Abdollah, et al.
Publicado: (2020)

Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives
por: Wellens, Judith, et al.
Publicado: (2023)

Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities
por: Boon, Lise, et al.
Publicado: (2016)

Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2019)

Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2022)

Matrix Metalloproteinase-9-Generated COOH-, but Not NH(2)-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity
por: Gouwy, Mieke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ls5520buto9bt0p6cpvfctct4j